Kanova Pharma has great Research and Development interfaced with analytical R & D and Quality Control (QC) laboratories, staffed by qualified and experienced personnel.
Core Technologies
With strong and able minds in R & D, Kanova Pharma is handling the following technologies:
Asymmetric synthesis of Chiral compounds
Organo-metallic compounds: chemistry and handling
Reduction involving diborane, Hydrogenation
Cryogenic reactions (temperatures up to -15°C)
Pressure reactions
Partial oxidation
High vacuum distillation
Any unit operations in organic synthesis
R&D Prowess
Science is at the heart of Kanova Pharma. Our R&D team works closely with global innovators and business development teams to generate prolific concepts and ideas to harness market needs and synergies across therapeutic areas.
Our core strength lies in our ability to excel in developing complex Chiral molecules through Catalysis & Enzymatic reactions driven by technology and backed by our dedicated teams in process chemistry and analytical development.